SOX2 was also reported to synergistically interacted with β-catenin, the downstream molecule of the WNT signal pathway, to regulate the transcription of a target gene to promote cell proliferation and tumorigenesis of human breast cancer [23]. The gene discussed is SOX2; the disease is breast carcinoma.